CAS: 2093386-51-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Thalidomide-NH-C6-NH2 (TFA) REF: IN-DA01V3QCCAS: 2093386-51-5 | 98% | To inquire | Tue 10 Dec 24 |
 | Thalidomide-NH-C6-NH2 TFA REF: TM-T18809CAS: 2093386-51-5 | 98% | To inquire | Tue 10 Dec 24 |
 | Pomalidomide Related Compound 11 Triflate REF: 4Z-P-178035CAS: 2093386-51-5 | - - - | To inquire | Mon 16 Dec 24 |
 | Thalidomide-NH-C6-NH2 (TFA) REF: 10-F987313CAS: 2093386-51-5 | - - - | To inquire | Thu 19 Dec 24 |
 | Thalidomide-NH-C6-NH2 TFA REF: 3D-TID38651CAS: 2093386-51-5 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA01V3QC
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Thalidomide-NH-C6-NH2 TFA
CAS:2093386-51-5
Thalidomide-based cereblon ligand linked to PROTAC technology as E3 ligase ligand-linker.
Formula:
C21H25F3N4O6
Purity:
98%
Color and Shape:
Solid
Molecular weight:
486.44
Ref: TM-T18809
| 2mg | 66.00 € | ||
| 5mg | 94.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Pomalidomide Related Compound 11 Triflate
CAS:2093386-51-5
Formula:
C19H24N4O4·C2HF3O2
Molecular weight:
372.43 114.02
Ref: 4Z-P-178035
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
Ref: 10-F987313
| 100mg | 691.00 € | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Thursday 19 Dec 2024
Thalidomide-NH-C6-NH2 TFA
CAS:2093386-51-5
Please enquire for more information about Thalidomide-NH-C6-NH2 TFA including the price, delivery time and more …
Formula:
C21H25F3N4O6
Purity:
Min. 95%
Molecular weight:
486.4 g/mol
Ref: 3D-TID38651
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
